Preoperative clinical factors are important determinants of the inflammatory state before and after heart surgery

ASAIO Journal

Volumn 53, Issue 3, 2007, Pages 316-319

  Magovern, James A ^a   Singh, Deepak ^a   Teekell Taylor, Leah ^a   Scalise, Deborah ^a   McGregor, Walter ^a   Magovern Jr , George ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH RISKS; INTENSIVE CARE UNITS; PROTEINS; TUMORS;

BASELINE INFLAMMATORY STATES; HEART SURGERY; MORTALITY RATES; POSTOPERATIVE INFLAMMATORY RESPONSE;

SURGERY;

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART EJECTION FRACTION; HEART SURGERY; HIGH RISK PATIENT; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; MALE; MEDIATOR; MORBIDITY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; SCORING SYSTEM; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MORBIDITY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34249102523     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e31804b19f7     Document Type: Article

References (16)

1. Levy JH, Tanaka KA: Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 75: S715-S720, 2003.
2. Wan S, LeClerc JL, Vincent JL: Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 112: 676-692, 1997.
3. Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM: Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg 68: 1107-1115, 1999.
4. Boyle EM, Pohlman TH, Johnson MC, et al: The systemic inflammatory response. Ann Thorac Surg 64: 531-537, 1997.
5. Velissaris T, Tang AT, Murray M, et al: A prospective randomized study to evaluate stress response during beating-heart and conventional coronary revascularization. Ann Thorac Surg 78: 506-512, 2004.
6. Parolari A, Mussoni L, Friggerio M, et al: Increased prothrombotic state lasting as long as one month after on-pump and off-pump. J Thorac Cardiovasc Surg 130: 303-308, 2005.
7. Magovern JA, Sakert T, Magovern GJ Jr, et al: A model that predicts morbidity and mortality after coronary artery bypass graft surgery. J Am Coll Cardiol 28: 1147-1153, 1996.
8. Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107: 363-369, 2003.
9. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115-126, 1999.
10. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565, 2002.
11. Biasucci LM, Liuzzo G, Grillo RL, et al: Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 99: 855-860, 1999.
12. Walter DH, Fichtlscherer S, Sellwig M, Auch-Schwelk W, Schachinger V, Zeiher AM: Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 37: 839-846, 2001.
13. Poldermans D, Bax JJ, Kertai MD, et al: Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107: 1848-1851, 2003.
14. Albert MA, Danielson E, Rifai N, et al: Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 286: 64-70, 2001.
15. Shishebor MH, Brennan ML, Aviles RJ, et al: Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 108: 426-431, 2003.
16. Naidu BV, Woolley SM, Farivar AS, et al: Simvastin ameliorates injury in an experimental model of lung ischemia-reperfusion. J Thorac Cardiovasc Surg 126: 482-489, 2003.